[Usefulness of F-18-fluorodeoxyglucose positron emission tomography for evaluating the efficacy of transient hepatic arterial chemoembolization for liver metastases of rectal cancer--a case report]

Gan To Kagaku Ryoho. 2004 Oct;31(11):1696-8.
[Article in Japanese]

Abstract

It is pointed out that there can be a discrepancy between the effect diagnosed by radiographic imaging and that by histological examination, when we treat patients with liver metastases of colorectal cancer by a transient hepatic arterial chemoembolization. We report a case of liver metastases of rectal cancer in which F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) was useful for evaluating the therapeutic efficacy for transient hepatic arterial chemoembolization. A 58-year-old man with synchronous liver metastases (H2) of rectal cancer underwent a low anterior resection, a partial hepatectomy, cholecystectomy, and ligation of the gastroduodenal artery. After these operations, the patient received 6 hepatic arterial injections with degradable starch microspheres (300-600 mg), adriamycin (30 mg), and mitomycin C (10 mg) for the remaining metastatic lesion (S7). Although abdominal CT scan revealed a partial response, FDG-PET did not show any abnormal deposits. Hepatic posterior segmentectomy was performed 7 months after the first operation. Histological examination did not show any viable tumor cells in the resected specimen.

Publication types

  • Case Reports

MeSH terms

  • Chemoembolization, Therapeutic*
  • Cholecystectomy
  • Doxorubicin / administration & dosage
  • Fluorodeoxyglucose F18*
  • Hepatectomy
  • Hepatic Artery
  • Humans
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy*
  • Male
  • Microspheres
  • Middle Aged
  • Mitomycin / administration & dosage
  • Positron-Emission Tomography*
  • Rectal Neoplasms / pathology*
  • Starch / administration & dosage

Substances

  • Fluorodeoxyglucose F18
  • Mitomycin
  • Doxorubicin
  • Starch